2000 - Hematological diseases in atomic bomb survivors, Nagasaki
Show all
Papers (107)：
Asami Yamada, Jun-Ichirou Yasunaga, Lihan Liang, Wenyi Zhang, Junya Sunagawa, Shinji Nakaoka, Shingo Iwami, Yasunori Kogure, Yuta Ito, Keisuke Kataoka, et al. Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma. Cancer science. 2023
Satsuki Owatari, Masahito Tokunaga, Daisuke Nakamura, Kimiharu Uozumi, Yasuko Sagara, Hitomi Nakamura, Koichi Haraguchi, Nobuaki Nakano, Makoto Yoshimitsu, Yoshikiyo Ito, et al. A decrease in newly diagnosed patients with adult T-cell leukemia/lymphoma in Kagoshima, a highly endemic area of HTLV-1 in southwestern Japan. Leuk Lymphoma. 2023. 1-9
Nahoko Komatsu, Masako Iwanaga, Yuri Hasegawa, Shoko Miura, Naoki Fuchi, Hiroyuki Moriuchi, Katsunori Yanagihara, Kiyonori Miura. Frequency of HTLV-1 seroconversion between pregnancies in Nagasaki, Japan, 2011-2018. Frontiers in Microbiology. 2022. 13
Yoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, Kenji Ishitsuka, Kenichi Ishizawa, Shigeki Ito, Masahiro Amano, Takashi Ishida, Naokuni Uike, Atae Utsunomiya, et al. Validation of the iATL-PI prognostic index in therapeutic decision-making for patients with smoldering and chronic ATL: a multicenter study. International Journal of Hematology. 2022. 117. 2. 206-215
Makoto Yamagishi, Miyuki Kubokawa, Yuta Kuze, Ayako Suzuki, Akari Yokomizo, Seiichiro Kobayashi, Makoto Nakashima, Junya Makiyama, Masako Iwanaga, Takahiro Fukuda, et al. Chronological genome and single-cell transcriptome integration characterizes the evolutionary process of adult T cell leukemia-lymphoma. Nature Communications. 2021. 12. 1. 4821-4821
蓬莱真喜子, 蓬莱真喜子, 鳥山愛生, 橋本美紀, 松尾真稔, 岩永正子, 城達郎, 高崎由美, 対馬秀樹, 加藤丈晴, et al. Differences in clinical features between MDS among atomic bomb survivors and therapy-related MDS. 日本血液学会学術集会抄録(Web). 2021. 83rd
Makiko Horai, Shinya Sato, Eo Toriyama, Miki Hashimoto, Masatoshi Matsuo, Masako Iwanaga, Tatsuro Jo, Yumi Takasaki, Hideki Tsushima, Shinichiro Yoshida, et al. Comparison of cytogenetic aberration between MDS in A-bomb survivors and therapy-related MDS. 2020
Adult T-cell Leukemia/Lymphoma
Springer Japan 2017 ISBN:9784431565215
Epidemiology An Introduction
2013 ISBN:9784884123727
Late hematological effects in the atomic bomb survivors. pp 67-72 in Shibata S, Yamashita S, Tomonaga M. (Eds.) Radiation Risk Perspectives. International Congress Series 1299
Elsevier, Tokyo 2007
Chapter 12. Incidence and clinical significance of PNH clone in myelodysplastic syndromes. Paroxysmal Nocturnal Hemoglobinuria and Related Disorders. Molecular Aspects of Pathogenesis.
2003
Lectures and oral presentations (6)：
Comparison of cytogenetic aberration between MDS in A-bomb survivors and therapy-related MDS.
(2020)
Long-term risk of ATL and HAM/TSP in HTLV-1 carriers: an update from JSPFAD
(JSHAD International Symposium: HTLV-1 infection: Peru, Australia, Japan 2019)
Epidemiological aspects of HTLV-1 infection and ATLL in Japan
(The 19th International conference on Human Retrovirology 2019)
Cancer Incidence in Possible Radiation Contaminated Areas, Bayan-Ulgii and Dornod
(The 10th IPPNW North Asia Regional Conference/3rd North & South Asian IPPNW Meeting, 2018)
The Japanese Society of Internal Medicine
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE CANCER ASSOCIATION
, International Retrovirology Association (IRVA)
, Japanese Society of HTLV-1 and Associated Disease
